Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Widmer N, Meylan P, Ivanyuk A, Aouri M, Decosterd LA, Buclin T.

Clin Pharmacokinet. 2010 Nov;49(11):741-65. doi: 10.2165/11534730-000000000-00000. Review.

PMID:
20923248
2.

Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations.

Davies BE.

J Antimicrob Chemother. 2010 Apr;65 Suppl 2:ii5-ii10. doi: 10.1093/jac/dkq015. Review.

3.

Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.

Okomo-Adhiambo M, Demmler-Harrison GJ, Deyde VM, Sheu TG, Xu X, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 May;54(5):1834-41. doi: 10.1128/AAC.01608-09. Epub 2010 Mar 1.

4.

Safety and pharmacokinetics of oseltamivir at standard and high dosages.

Dutkowski R, Smith JR, Davies BE.

Int J Antimicrob Agents. 2010 May;35(5):461-7. doi: 10.1016/j.ijantimicag.2009.12.023. Epub 2010 Mar 1.

PMID:
20189775
5.

Pharmacokinetics of metformin during pregnancy.

Eyal S, Easterling TR, Carr D, Umans JG, Miodovnik M, Hankins GD, Clark SM, Risler L, Wang J, Kelly EJ, Shen DD, Hebert MF.

Drug Metab Dispos. 2010 May;38(5):833-40. doi: 10.1124/dmd.109.031245. Epub 2010 Jan 29.

6.

2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia.

Hewagama S, Walker SP, Stuart RL, Gordon C, Johnson PD, Friedman ND, O'Reilly M, Cheng AC, Giles ML.

Clin Infect Dis. 2010 Mar 1;50(5):686-90. doi: 10.1086/650460.

PMID:
20100064
7.

Severe 2009 H1N1 influenza in pregnant and postpartum women in California.

Louie JK, Acosta M, Jamieson DJ, Honein MA; California Pandemic (H1N1) Working Group..

N Engl J Med. 2010 Jan 7;362(1):27-35. doi: 10.1056/NEJMoa0910444. Epub 2009 Dec 23.

8.

H1N1 2009 influenza virus infection during pregnancy in the USA.

Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, Lindstrom S, Louie JK, Christ CM, Bohm SR, Fonseca VP, Ritger KA, Kuhles DJ, Eggers P, Bruce H, Davidson HA, Lutterloh E, Harris ML, Burke C, Cocoros N, Finelli L, MacFarlane KF, Shu B, Olsen SJ; Novel Influenza A (H1N1) Pregnancy Working Group..

Lancet. 2009 Aug 8;374(9688):451-8. doi: 10.1016/S0140-6736(09)61304-0. Epub 2009 Jul 28.

PMID:
19643469
9.

Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women.

Tanaka T, Nakajima K, Murashima A, Garcia-Bournissen F, Koren G, Ito S.

CMAJ. 2009 Jul 7;181(1-2):55-8. doi: 10.1503/cmaj.090866. Epub 2009 Jun 15. Review. No abstract available.

10.

Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team., Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM.

N Engl J Med. 2009 Jun 18;360(25):2605-15. doi: 10.1056/NEJMoa0903810. Epub 2009 May 7. Erratum in: N Engl J Med. 2009 Jul 2;361(1):102.

11.

Prediction of the pharmacodynamically linked variable of oseltamivir carboxylate for influenza A virus using an in vitro hollow-fiber infection model system.

McSharry JJ, Weng Q, Brown A, Kulawy R, Drusano GL.

Antimicrob Agents Chemother. 2009 Jun;53(6):2375-81. doi: 10.1128/AAC.00167-09. Epub 2009 Apr 13.

12.

Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice.

Hebert MF, Ma X, Naraharisetti SB, Krudys KM, Umans JG, Hankins GD, Caritis SN, Miodovnik M, Mattison DR, Unadkat JD, Kelly EJ, Blough D, Cobelli C, Ahmed MS, Snodgrass WR, Carr DB, Easterling TR, Vicini P; Obstetric-Fetal Pharmacology Research Unit Network..

Clin Pharmacol Ther. 2009 Jun;85(6):607-14. doi: 10.1038/clpt.2009.5. Epub 2009 Mar 18.

13.

Clonidine pharmacokinetics in pregnancy.

Buchanan ML, Easterling TR, Carr DB, Shen DD, Risler LJ, Nelson WL, Mattison DR, Hebert MF.

Drug Metab Dispos. 2009 Apr;37(4):702-5. doi: 10.1124/dmd.108.024984. Epub 2008 Dec 30.

14.

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.

Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NS; Centers for Disease Control and Prevention (CDC).; Advisory Committee on Immunization Practices (ACIP)..

MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60.

15.

Pandemic influenza and pregnant women.

Rasmussen SA, Jamieson DJ, Bresee JS.

Emerg Infect Dis. 2008 Jan;14(1):95-100. doi: 10.3201/eid1401.070667.

16.

Pandemic influenza and pregnancy: a call for preparedness planning.

Beigi RH.

Obstet Gynecol. 2007 May;109(5):1193-6.

PMID:
17470605
17.

Obstetric clinical pharmacology: coming of age.

Zajicek A, Giacoia GP.

Clin Pharmacol Ther. 2007 Apr;81(4):481-2.

PMID:
17375105
18.

Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies.

Andrew MA, Easterling TR, Carr DB, Shen D, Buchanan ML, Rutherford T, Bennett R, Vicini P, Hebert MF.

Clin Pharmacol Ther. 2007 Apr;81(4):547-56. Epub 2007 Feb 28.

PMID:
17329990
19.

Hospitalizations with respiratory illness among pregnant women during influenza season.

Cox S, Posner SF, McPheeters M, Jamieson DJ, Kourtis AP, Meikle S.

Obstet Gynecol. 2006 Jun;107(6):1315-22.

PMID:
16738158
20.

Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.

Anderson GD.

Clin Pharmacokinet. 2005;44(10):989-1008. Review.

PMID:
16176115

Supplemental Content

Support Center